
by Unlearn
Unlearn uses AI to create digital twins of clinical trial participants, forecasting each person's clinical outcomes. Sponsors use them to design, run and re-analyze trials.
Web appContact for pricing
Step 1: Talk to Unlearn about where your study stands.
Step 2: Choose an entry point: in design, in progress or after readout.
Step 3: Model the expected participants and test design options.
Step 4: Apply digital twin analyses to enrolled participants.
Step 5: Use the readout to inform the next study design.
It is an AI-generated forecast of one participant's clinical outcomes.
At any point in a study: before protocol finalization, from first patient in through readout, and after readout.
Yes. The site describes strengthening single-arm evidence, with an example re-analysis where statistical power rose from 70% to 86% compared with propensity score matching.
Announcements on the site mention Alzheimer's disease, Huntington's disease and ALS.
ABodyBuilder2ABodyBuilder2 is a web tool from the Oxford Protein Informatics Group that models antibody Fv regions with machine learning. You submit heavy and light chain sequences and get a structure model.